Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Accenture
Daiichi Sankyo
Teva
Argus Health
Julphar
US Army
Baxter

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,601,848

« Back to Dashboard

Summary for Patent: 5,601,848
Title: Methods for the treatment of gastrointestinal disorders
Abstract:Method for the treatment of human and lower animals having an infectious gastrointestinal disorder, comprising the step of administering from about 50 to about 5000 milligrams of bismuth to said subject, per day, for from 3 to 56 days. Preferred processes also include a step for performing a diagnostic step on the subject for detection of campylobacter-like organism infection of the subject.
Inventor(s): Marshall; Barry J. (Perth, AU)
Assignee: The Procter & Gamble Company (Cincinnati, OH)
Application Number:07/070,857
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 5,601,848

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,601,848

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 79261 ➤ Try a Free Trial
Austria 79264 ➤ Try a Free Trial
Belgium 904922 ➤ Try a Free Trial
Germany 3619733 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
Chubb
QuintilesIMS
UBS
Daiichi Sankyo
McKesson
AstraZeneca
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.